IL41619A - N-propanolamine sites and their preparation - Google Patents

N-propanolamine sites and their preparation

Info

Publication number
IL41619A
IL41619A IL41619A IL4161973A IL41619A IL 41619 A IL41619 A IL 41619A IL 41619 A IL41619 A IL 41619A IL 4161973 A IL4161973 A IL 4161973A IL 41619 A IL41619 A IL 41619A
Authority
IL
Israel
Prior art keywords
group
ether
phenyl
general formula
isobutyl
Prior art date
Application number
IL41619A
Other languages
English (en)
Hebrew (he)
Other versions
IL41619A0 (en
Original Assignee
Cerm Cent Europ Rech Mauvernay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerm Cent Europ Rech Mauvernay filed Critical Cerm Cent Europ Rech Mauvernay
Publication of IL41619A0 publication Critical patent/IL41619A0/xx
Publication of IL41619A publication Critical patent/IL41619A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
IL41619A 1972-03-06 1973-02-26 N-propanolamine sites and their preparation IL41619A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7207647A FR2174655B1 (de) 1972-03-06 1972-03-06

Publications (2)

Publication Number Publication Date
IL41619A0 IL41619A0 (en) 1973-04-30
IL41619A true IL41619A (en) 1976-05-31

Family

ID=9094658

Family Applications (1)

Application Number Title Priority Date Filing Date
IL41619A IL41619A (en) 1972-03-06 1973-02-26 N-propanolamine sites and their preparation

Country Status (12)

Country Link
US (2) US3962238A (de)
JP (1) JPS4899127A (de)
BE (1) BE795735A (de)
CA (2) CA1015360A (de)
CH (1) CH556815A (de)
DE (1) DE2310918C3 (de)
ES (1) ES412203A1 (de)
FR (1) FR2174655B1 (de)
GB (1) GB1377327A (de)
IL (1) IL41619A (de)
NL (1) NL153190C (de)
ZA (1) ZA731411B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378024A1 (fr) * 1977-01-25 1978-08-18 Cerm Cent Europ Rech Mauvernay Nouvelle propylamine substituee, obtention et application
FR2472567A1 (fr) 1979-12-28 1981-07-03 Cerm Cent Europ Rech Mauvernay Ethers de 1- (2-propynyloxy)-2-amino-3-propanol, leur preparation et leur application en therapeutique
EP0096720B1 (de) * 1981-12-28 1988-03-02 Carter-Wallace Inc. Verfahren zur Herstellung von B-[(2-Methylpropoxy)-methyl]-N-phenyl-N-(phenylmethyl)-1-pyrrolidinethanamin
US4405811A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Severely sterically hindered tertiary amino compounds
US4483833A (en) * 1982-01-18 1984-11-20 Exxon Research & Engineering Co. Process for selective removal of H2 S from mixtures containing H22 with heterocyclic tertiary aminoalkanols
US4405580A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Process for selective removal of H2 S from mixtures containing H22 with tertiary amino azabicyclic alcohols
US4405585A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Process for the selective removal of hydrogen sulfide from gaseous mixtures with severely sterically hindered secondary aminoether alcohols
US4417075A (en) * 1982-01-18 1983-11-22 Exxon Research And Engineering Co. Di-(Secondary and tertiaryalkylaminoalkoxy)alkanes
US4508692A (en) * 1982-01-18 1985-04-02 Exxon Research & Engineering Co. Process for the selective removal of hydrogen sulfide from gaseous mixtures with strongly basic tertiary amino compounds
US4762934A (en) * 1982-01-18 1988-08-09 Exxon Research And Engineering Company Diaminoether compositions
US4405581A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Process for the selective removal of hydrogen sulfide from gaseous mixtures with severely sterically hindered secondary amino compounds
US4471138A (en) * 1982-01-18 1984-09-11 Exxon Research And Engineering Co. Severely sterically hindered secondary aminoether alcohols
US4405582A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Process for selective removal of H2 S from mixtures containing H22 using diaminoether solutions
US4405583A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Process for selective removal of H2 S from mixtures containing H22 using di-severely sterically hindered secondary aminoethers
DK156396C (da) * 1983-09-27 1990-01-08 Cerm Cent Europ Rech Mauvernay 2-(n-pyrrolidino)-3-isobutoxy-n-substituerede phenyl-n-benzyl-propylamin-forbindelser og farmaceutiske midler indeholdende disse
GB8330197D0 (en) * 1983-11-11 1983-12-21 Akzo Nv Ether of n-propanolamine derivative
DE3468684D1 (de) * 1983-11-11 1988-02-18 Akzo Nv Ether of n-propanolamine derivative
US4758563A (en) * 1986-02-12 1988-07-19 Mcneilab, Inc. 3-alkoxy-2-aminopropyamines, cardiovascular compositions and use
US4727072A (en) * 1986-02-12 1988-02-23 Mcneilab, Inc. 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents
DE3726633A1 (de) * 1987-08-11 1989-02-23 Boehringer Mannheim Gmbh Neue 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE3726632A1 (de) * 1987-08-11 1989-05-18 Boehringer Mannheim Gmbh 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US4888335A (en) 1988-07-25 1989-12-19 Mcneilab, Inc. 3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents
US5185362A (en) * 1988-09-14 1993-02-09 Mcneilab, Inc. Diphenylamine cardiovascular agents, compositions and use
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
NZ577031A (en) * 2003-05-30 2010-09-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-CO inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
RU2007106714A (ru) * 2004-07-26 2008-09-10 Байер Шеринг Фарма Аг (De) Лечение легочной гипертензии путем ингаляции илопростата с препаратом микрочастиц
AP2007003979A0 (en) * 2004-11-23 2007-06-30 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for thetreatment of lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
ATE551059T1 (de) * 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
EP2351569B1 (de) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Kombinationstherapie mit Fasudil zur Behandlung von pulmonaler Hypertonie
WO2007054896A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US20070238716A1 (en) * 2006-03-14 2007-10-11 Murthy Ayanampudi S R Statin stabilizing dosage formulations
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8748648B2 (en) * 2007-09-06 2014-06-10 Nektar Therapeutics Oligomer-calcium channel blocker conjugates
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2016098128A1 (en) 2014-12-16 2016-06-23 Council Of Scientific & Industrial Research Process for the preparation of bepridil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH268689A (de) * 1947-07-01 1950-05-31 Spojene Farmaceuticke Z Narodn Verfahren zur Darstellung eines biologisch wirksamen Phenyläthylendiaminderivates.
US2600301A (en) * 1948-06-04 1952-06-10 Smith Kline French Lab N-substituted-beta halo-ethyl amines
NL101813C (de) * 1955-04-09
GB1219609A (en) * 1968-07-19 1971-01-20 Koninklijke Pharma Fab Nv Diphenylmethoxyethylamino derivatives

Also Published As

Publication number Publication date
ZA731411B (en) 1974-04-24
JPS4899127A (de) 1973-12-15
USRE30577E (en) 1981-04-14
IL41619A0 (en) 1973-04-30
BE795735A (fr) 1973-06-18
US3962238A (en) 1976-06-08
FR2174655A1 (de) 1973-10-19
GB1377327A (en) 1974-12-11
FR2174655B1 (de) 1975-08-01
ES412203A1 (es) 1975-12-01
DE2310918A1 (de) 1973-09-20
CA1015360A (fr) 1977-08-09
DE2310918B2 (de) 1979-10-25
NL153190C (nl) 1980-12-15
DE2310918C3 (de) 1980-07-03
NL153190B (nl) 1977-05-16
NL7303117A (de) 1973-09-10
CH556815A (fr) 1974-12-13
CA1048027A (fr) 1979-02-06

Similar Documents

Publication Publication Date Title
IL41619A (en) N-propanolamine sites and their preparation
PL239687A1 (en) Process for preparing novel 2-/4-/diphenylmethyl/-1-piperazinyl/-acetic acids
GB1086192A (en) Phenylcyclopropane derivatives
GB1187259A (en) New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture
ES8203352A1 (es) Procedimiento para la preparacion de 1-(4-clorobencidril)-4-(2,3-dihidroxipropil)-piperacina
ES419935A1 (es) Procedimiento para la preparacion de sulfamidas.
CY1312A (en) 2-(4-(diphenylmethylene)-1-piperidinyl)-acetic acids and their amides,their preparation and pharmaceutical preparations containing them
NO165144C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av interne salter av aminopyridiniumhydroksidog deres tilsvarende salter.
GB1253825A (en) N-(phenylalkyl)-acylamides and their preparation
GB1363195A (en) Propenylamine derivatives and process for the production thereof
GB1176757A (en) Quinuclidine Carboxylic Acid Amides
GB1225462A (de)
GB1392908A (en) Salts thereof
GB862721A (en) Dialkylaminoethyl derivatives of salicylamides
GB874206A (en) Basic derivatives of salicylamide
GB1120186A (en) Cyclohexene amino acid derivatives and process for their preparation
GB850333A (en) Phenylacetic esters having two basic substituents and production thereof
GB889223A (en) Phenylpiperazinylalkyl esters and amides
ES319943A1 (es) Procedimiento para la obtencion de 3',4',5'-trimetoxi-3-aminoacrilofenona.
GB1377610A (en) 5-piperidine-4-spiro- oxazolidinones method for their preparation and applications thereof
GB1082571A (en) New heterocyclic amino compounds, their salts and a process for the preparation thereof
GB1244881A (en) New piperidine derivatives, process for their production and preparations containing same
FR2323378A1 (fr) Nouvelles amidines ayant des proprietes antiarythmiques
JPS57165381A (en) Novel piperazing derivative and its preparation
JPS55145669A (en) 8,10-diazaprostanoic acid derivative and its preparation